enVVeno Medical Corporation
enVVeno Medical Corporation (NVNO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · NVNO · as of Sep 30, 2025
Ownership Breakdown
40
Institutional Holders
▲ 2 vs Q2
$5.43M
Total Inst. Value
▼ $14.88M vs Q2
16,503
Shares Outstanding
freeFloat 73.81%
5.98M
13F Shares Held
▲ 885,267 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
NVNO largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC surgical & medical instruments & apparatus | 1.76M | 8.53% | 8.53% | $1.59B | Nov 14, 2025 | ▲ 474.1K |
KINGDON CAPITAL MANAGEMENT, L.L.C. surgical & medical instruments & apparatus | 1.36M | 6.59% | 6.59% | $1.23B | Nov 14, 2025 | ▲ 500.0K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 861.2K | 4.18% | 4.18% | $780.24M | Nov 7, 2025 | ▲ 162.9K |
CM MANAGEMENT, LLC surgical & medical instruments & apparatus | 600.0K | 2.91% | 2.91% | $543.66M | Nov 13, 2025 | NEW |
WESTSIDE INVESTMENT MANAGEMENT, INC. surgical & medical instruments & apparatus | 212.8K | 1.03% | 1.03% | $192.82M | Nov 4, 2025 | ▼ 66.7K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 201.2K | 97.62% | 97.62% | $182.37M | Nov 12, 2025 | ▲ 1.7K |
JPMORGAN CHASE & CO surgical & medical instruments & apparatus | 182.3K | 88.44% | 88.44% | $165.20M | Nov 26, 2025 | ▲ 22 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP surgical & medical instruments & apparatus | 154.5K | 74.93% | 74.93% | $139.97M | Nov 14, 2025 | NEW |
JANE STREET GROUP, LLC surgical & medical instruments & apparatus | 71.8K | 34.81% | 34.81% | $65.03M | Nov 14, 2025 | ▲ 58.9K |
BANK OF AMERICA CORP /DE/ surgical & medical instruments & apparatus | 67.9K | 32.94% | 32.94% | $61.52M | Feb 3, 2026 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
16
Increased
+1.33M shares11
New Positions
first time holders5
Decreased
−163.6K shares10
Sold Out
fully exitedNet shares change (top 50)
+1.17M
+1.33M / −163.6K
Net new holders
+12
11 new / 10 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
NVNO insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Duhay Francis director | Mar 12, 2026 | Sale | 140 | $11.52 | $1.6K | 2.5K | Form 4 ↗ |
BERMAN ROBERT ANDREW Chief Executive Officer | Dec 16, 2025 | J-Other | 200,000 | — | — | 0 | Form 4 ↗ |
Alavi Hamed Chief Technology Officer | Dec 16, 2025 | J-Other | 50,000 | — | — | 0 | Form 4 ↗ |
Glickman Marc H. SVP & Chief Medical Officer | Dec 16, 2025 | J-Other | 100,000 | — | — | 0 | Form 4 ↗ |
Duhay Francis director | Dec 11, 2025 | Award | 135,883 | $0.33 | $44.2K | 135.9K | Form 4 ↗ |
Gray Robert director | Dec 11, 2025 | Award | 135,883 | $0.33 | $44.2K | 135.9K | Form 4 ↗ |
Jenusaitis Matthew director | Dec 11, 2025 | Award | 135,883 | $0.33 | $44.2K | 135.9K | Form 4 ↗ |
Shrivastava Sanjay director | Dec 11, 2025 | Award | 135,883 | $0.33 | $44.2K | 135.9K | Form 4 ↗ |
Duhay Francis director | Dec 11, 2025 | Sale | 4,900 | $0.36 | $1.7K | 92.5K | Form 4 ↗ |
Duhay Francis director | Sep 15, 2025 | Sale | 4,900 | $0.83 | $4.1K | 97.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
enVVeno Medical Corporation (NVNO) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 26.19%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of enVVeno Medical Corporation is PERCEPTIVE ADVISORS LLC, holding approximately 1.76 million shares — equal to 8.53% of outstanding shares — as of September 30, 2025.
A total of 40 institutional investors currently hold NVNO stock, with a combined institutional value of approximately $5,434,682 as of the most recent 13F filing period.
Frequently asked questions
NVNO ownershipenVVeno Medical Corporation (NVNO) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is PERCEPTIVE ADVISORS LLC with a 8.53% stake. Company insiders hold 26.19%. Data sourced from SEC Form 13F as of September 30, 2025.